In allogeneic mouse models of GVHD, pharmacological blockade of CD73 with APCP (days 0–6) [111] or APCP (twice weekly) [112] increased splenic CD4+ and CD8+ T cell numbers and serum IFN-γ and IL-6 concentrations and mouse mortality. Here, IL6 is linked to graft versus host disease.